Clearside Biomedical (CLSD) Competitors $0.91 -0.01 (-1.12%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$0.90 -0.01 (-1.17%) As of 04/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLSD vs. ATAI, TERN, PROK, ANNX, GOSS, CMPS, SEPN, CADL, DSGN, and AVIRShould you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include Atai Life Sciences (ATAI), Terns Pharmaceuticals (TERN), ProKidney (PROK), Annexon (ANNX), Gossamer Bio (GOSS), COMPASS Pathways (CMPS), Septerna (SEPN), Candel Therapeutics (CADL), Design Therapeutics (DSGN), and Atea Pharmaceuticals (AVIR). These companies are all part of the "pharmaceutical products" industry. Clearside Biomedical vs. Atai Life Sciences Terns Pharmaceuticals ProKidney Annexon Gossamer Bio COMPASS Pathways Septerna Candel Therapeutics Design Therapeutics Atea Pharmaceuticals Atai Life Sciences (NASDAQ:ATAI) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Does the MarketBeat Community favor ATAI or CLSD? Clearside Biomedical received 39 more outperform votes than Atai Life Sciences when rated by MarketBeat users. Likewise, 67.45% of users gave Clearside Biomedical an outperform vote while only 66.53% of users gave Atai Life Sciences an outperform vote. CompanyUnderperformOutperformAtai Life SciencesOutperform Votes33466.53% Underperform Votes16833.47% Clearside BiomedicalOutperform Votes37367.45% Underperform Votes18032.55% Which has more risk & volatility, ATAI or CLSD? Atai Life Sciences has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Clearside Biomedical has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500. Do analysts rate ATAI or CLSD? Atai Life Sciences presently has a consensus target price of $9.00, suggesting a potential upside of 625.81%. Clearside Biomedical has a consensus target price of $5.25, suggesting a potential upside of 478.45%. Given Atai Life Sciences' higher probable upside, analysts plainly believe Atai Life Sciences is more favorable than Clearside Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Atai Life Sciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ATAI or CLSD? In the previous week, Clearside Biomedical had 15 more articles in the media than Atai Life Sciences. MarketBeat recorded 17 mentions for Clearside Biomedical and 2 mentions for Atai Life Sciences. Atai Life Sciences' average media sentiment score of 0.96 beat Clearside Biomedical's score of 0.28 indicating that Atai Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Atai Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clearside Biomedical 1 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, ATAI or CLSD? Clearside Biomedical has higher revenue and earnings than Atai Life Sciences. Clearside Biomedical is trading at a lower price-to-earnings ratio than Atai Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtai Life Sciences$308K798.37-$40.22M-$0.93-1.33Clearside Biomedical$7.70M8.94-$32.49M-$0.47-1.93 Do institutionals & insiders have more ownership in ATAI or CLSD? 28.4% of Atai Life Sciences shares are owned by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are owned by institutional investors. 31.2% of Atai Life Sciences shares are owned by company insiders. Comparatively, 9.2% of Clearside Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is ATAI or CLSD more profitable? Atai Life Sciences has a net margin of 0.00% compared to Clearside Biomedical's net margin of -413.83%. Clearside Biomedical's return on equity of 0.00% beat Atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Atai Life SciencesN/A -65.75% -52.71% Clearside Biomedical -413.83%N/A -92.90% SummaryAtai Life Sciences and Clearside Biomedical tied by winning 8 of the 16 factors compared between the two stocks. Remove Ads Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLSD vs. The Competition Export to ExcelMetricClearside BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.84M$6.76B$5.55B$7.86BDividend YieldN/A2.80%5.35%4.04%P/E Ratio-2.027.0923.4418.67Price / Sales8.94199.59367.8687.31Price / CashN/A65.6738.1634.64Price / Book-3.635.966.634.09Net Income-$32.49M$142.11M$3.20B$246.93M7 Day Performance-11.02%-7.60%-4.99%-3.16%1 Month Performance5.57%-12.56%-1.56%-6.74%1 Year Performance-35.17%-13.53%8.73%-0.49% Clearside Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLSDClearside Biomedical2.3198 of 5 stars$0.91-1.1%$5.25+478.4%-42.6%$68.84M$7.70M-2.0230Earnings ReportAnalyst ForecastATAIAtai Life Sciences3.6591 of 5 stars$1.57+8.3%$9.00+473.2%-33.3%$311.34M$308,000.00-1.9480Gap UpTERNTerns Pharmaceuticals4.3259 of 5 stars$3.51+4.8%$18.30+421.4%-63.9%$298.14MN/A-2.9740PROKProKidney1.925 of 5 stars$1.02+6.2%$5.00+390.2%-48.1%$297.50M$76,000.00-1.853ANNXAnnexon2.2458 of 5 stars$2.70+12.5%$15.80+485.2%-72.7%$296.22MN/A-2.5760Positive NewsGOSSGossamer Bio3.9241 of 5 stars$1.28-7.9%$9.20+618.8%-21.7%$290.84M$114.70M-4.00180Positive NewsCMPSCOMPASS Pathways3.3627 of 5 stars$3.11+0.3%$21.83+602.0%-71.2%$288.21MN/A-1.41120SEPNSepterna2.1221 of 5 stars$6.37+7.6%$34.00+433.8%N/A$282.85M$981,000.000.00N/AEarnings ReportCADLCandel Therapeutics2.3315 of 5 stars$8.66+7.4%$21.00+142.5%+218.3%$281.24M$120,000.00-5.0160Gap UpDSGNDesign Therapeutics1.9849 of 5 stars$4.93+6.0%$8.00+62.3%-10.2%$279.84MN/A-5.8040Gap UpAVIRAtea Pharmaceuticals2.6318 of 5 stars$3.20-0.6%$6.88+115.0%-28.8%$273.68MN/A-1.5570 Remove Ads Related Companies and Tools Related Companies Atai Life Sciences Competitors Terns Pharmaceuticals Competitors ProKidney Competitors Annexon Competitors Gossamer Bio Competitors COMPASS Pathways Competitors Septerna Competitors Candel Therapeutics Competitors Design Therapeutics Competitors Atea Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLSD) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
